In addition to the hormone receptor-based biological classification system noted above, BC can be characterized into molecular subtypes based on gene expression patterns: Luminal A and B, HER2-enriched, and Basal-like (BL) breast cancer. Here, ERBB2 is linked to breast carcinoma.